Morgan Stanley analyst Erin Wright maintained a Buy rating on Cardinal Health (CAH – Research Report) today and set a price target of $136.00.

Cardinal Health (NYSE:CAH – Free Report) had its price objective hoisted by JPMorgan Chase & Co. from $132.00 to $142.00 in a ...

Cardinal Health, Inc. CAH is scheduled to report fiscal second-quarter 2025 results on Jan. 30, before the opening bell. In ...

We recently published a list of Jim Cramer’s Latest Calls: 10 Stocks to Buy or Sell. In this article, we are going to take a ...

Cardinal Health, Inc. operates as a healthcare services and products company in the United States, Canada, Europe, Asia, and internationally. It provides customized solutions for hospitals ...

Cardinal Health prepares to enter direct patient care ... renamed Global Medical Products and Distribution; and the $1.2 billion unit manufacturing and delivering radioactive diagnostic drugs ...

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions.

With these words the newly created Philippine Cardinal Pablo Virgilio David y ... both local and foreign,” the rise of serious mental health problems, and “various forms of addiction in ...

Canadians Cardinal Michael Czerny and sculptor Timothy P. Schmalz on Thursday in Rome spoke about evangelization through art as part of festivities linked to the Jan. 24–26 Jubilee of the World ...

Cardinal Christoph Schönborn, OP, concluded his term as archbishop of Vienna, Austria, on Wednesday, his 80th birthday, when Pope Francis accepted his resignation. Schönborn, a theologian who ...

View Cardinal Health, Inc. (CAH) current and estimated P/E ratio data provided by Seeking Alpha.

TD Cowen upgraded Cardinal Health (CAH) to Buy from Hold with a price target of $144, up from $130. The firm believes new customers, strong utilization trends, and recent acquisitions into ...